WEBCAST

Regimen Choice and Newly Approved Agents in Relapsed/Refractory Multiple Myeloma

Watch the webcast of renowned experts actively engaged in the care of patients with multiple myeloma debate topics on treating patients with high-risk smoldering, transplant, optimal approaches to BCMA targeting and much more, held in conjunction with the 2021 Society of Hematology Oncology Annual Meeting. #SOHO2021.

Expires Sep 30, 2022

Faculty

Sagar Lonial, MD, FACP
Winship Cancer Institute of Emory University Atlanta, Georgia

Thomas Martin, MD
Helen Diller Family Comprehensive Cancer Center San Francisco, California

Krina Patel, MD MSc
MD Anderson Cancer Center Houston, Texas

WEBCAST

CAR T-Cell Therapy for Lymphoma and Myeloma in Clinical Practice

This webcast features three renowned experts actively engaged in the care of patients with lymphoma and myeloma as they present the most up-to-date information from a symposium that was held in conjunction with the 2021 Society of Hematology Oncology Annual Meeting. #SOHO2021

Expires Sep 28, 2022

Faculty

Christopher Flowers, MD

MD Anderson Cancer Center
Houston, Texas

Loretta Nastoupil, MD

MD Anderson Cancer Center
Houston, Texas

Noopur Raje, MD

Massachusetts General Hospital
Boston, Massachusetts

WEBCAST

Expert Tumor Board to Address Challenging Cases of Relapsed/Refractory Aggressive and Indolent Lymphomas

This webcast will provide expert interpretation of emerging data and guidance regarding current and emerging therapies for the treatment of patients with various aggressive and indolent lymphoma subtypes held in conjunction with the 2021 Pan Pacific Lymphoma Conference. #PPLC21

Expires Sep 14, 2022

Chair

Matthew Lunning, DO, FACP
University of Nebraska Medical Center Omaha, Nebraska

Faculty

Ranjana Advani, MD

Stanford Cancer Institute
Palo Alto, California

Andrew Zelenetz, MD, PhD

Weill Cornell Medicine
New York, New York

WEBCAST

Current and Emerging CAR T-Cell and Other Cellular Therapies for the Treatment of Patients with Hematologic Malignancies

This webcast on The Treatment of Patients with Hematologic Malignancies was presented at the 2021 Pan Pacific Lymphoma Conference and features expert interpretation of emerging data and guidance regarding current and emerging therapies for the treatment of patients with lymphoma and multiple myeloma. #PPLC21

Expires Sep 13, 2022

Chair

Julie Vose, MD, MBA
University of Nebraska Medical Center Omaha, Nebraska

Faculty

Nina Shah, MD
University of California San Francisco San Francisco, California

Tara Graff, DO
Mission Blood + Cancer Des Moines, Iowa

WEBCAST

Practical Aspects of Incorporating CAR T-Cell Therapy into Your Practice

Hear from 3 renowned experts actively engaged in the care of patients with lymphoma and multiple myeloma from an independent satellite symposium that took place following the 2021 American Society of Clinical Oncology Meeting. #ASCO21

Expires Sep 9, 2022

Chair

Sagar Lonial, MD, FACP
Winship Cancer Institute of Emory University Atlanta, Georgia

Faculty

Loretta Nastoupil, MD
The University of Texas MD Anderson Cancer Center Houston, Texas

Nina Shah, MD
University of California San Francisco San Francisco, California

WEBCAST

New Targets, New Agents, New Combinations: Navigating the New Landscape in Relapsed/Refractory Multiple Myeloma

Hear from 3 renowned experts actively engaged in the care of patients with multiple myeloma from an independent satellite symposium that took place following the 2021 American Society of Clinical Oncology Meeting. #ASCO21

Expires August 4 , 2022

Chair

Noopur Raje, MD
Massachusetts General Hospital Boston, Massachusetts

Faculty

Joseph Mikhael, MD, MEd, FRCPC, FACP

City of Hope Cancer Center
Adjunct Professor, College of Health Solutions, Arizona State University
Houston, Texas

Krina Patel, MD

The University of Texas MD Anderson Cancer Center
Houston, Texas

WEBCAST

Experts Debate: Optimal Approaches to the Treatment of Multiple Myeloma

Watch 4 renowned experts actively engaged in the care of patients with multiple myeloma debate topics on treating patients with high-risk smoldering, transplant, optimal approaches to BCMA targeting and much more from the 2021 American Society of Hematology meeting. #ASH2021.

Expires January 15 , 2022

Chair

Sagar Lonial, MD, FACP
Emory University School of Medicine Atlanta, Georgia

Faculty

Kenneth Anderson, MD
ana-Farber Cancer Institute Boston, Massachusetts

Peter Sonneveld, MD
University Medical Center Rotterdam Rotterdam, Holland, Netherlands

Peter Voorhees, MD
evine Cancer Institute, Atrium Health Charlotte, North Carolina

WEBCAST

Nursing Perspectives on the Increasing Role of PARP Inhibitors for Ovarian Cancer

Watch a stimulating and informative conversation about current practices to optimize the use of PARP inhibitors for your patients with ovarian cancer from the September 26, 2020  Oncology Nursing Society virtual symposium

Expires November 18, 2021

Expires November 18 , 2022